Metal Nanoparticles: Current Advances in Design and Development for Antineoplastic Applications
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Nanoscience".
Deadline for manuscript submissions: closed (31 January 2023) | Viewed by 18375
Special Issue Editors
Interests: nanoparticles; nanomedicine; experimental chemotherapy; tumor microenvironment; multidrug resistance; radioresistance; epithelial-mesenchymal transition; transcriptional regulation; combination therapy
Special Issue Information
Dear Colleagues,
The rapidly developing field of nanotechnology offers new possibilities for medical uses. In particular, the potential of using metal-based nanoparticles for oncotherapy attracts interest from multidisciplinary areas. Metal nanoparticles exhibit intrinsic cytotoxicity, are ideal tools for drug delivery, radio- and chemosensitization, and could therefore be exploited upon targeted elimination of malignant cells. Although many of the cellular and molecular changes induced by metal-based nanoparticles have been identified, a complete understanding of how the properties of nanoparticles influence interactions with living systems awaits further studies. Research is warranted for the elucidation of the molecular mechanisms triggered by simple and complex metal nanoparticles on multidrug-resistant, radiation-resistant cancer, or cancer stem cells. Likewise, a detailed characterization of the disrupted communication between malignant and stromal cells by nanomaterials in the tumor microenvironment is necessary. Insights and knowledge of these features would shape and refine nanoparticle-based treatment strategies and advances, reaching the ultimate goal of suppressing cancer invasion and metastasis.
This Special Issue is aimed at providing an insight into the latest advances in the field of nanomedicine, with emphasis on the benefits, limitations, and future directions of utilizing metal nanoparticles in oncotherapy. We encourage researchers to share their views and news on these exciting topics. Original research papers and review articles are warmly welcomed.
Dr. Mónika Kiricsi
Prof. Dr. Imre Miklós Boros
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Metal nanoparticles
- Hybrid metal nanoparticles
- Core-shell metal nanoparticles
- Antineoplastic activity
- Suppression of metastasis
- Molecular mechanism
- Tumor microenvironment
- Paracrine communication within the tumor
- Multidrug resistance
- Radio-resistance
- Chemo- and radiosensitization
- Combination therapy